{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018725","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2025-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.932821+00:00","generated_at":"2026-05-17T02:57:58.790638+00:00","sec_items":["1.01","3.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"confidence":"high","headline":"Oragenics settles Ladenburg dispute for $700K; regains NYSE American compliance","bullets":["Paid $700K to Ladenburg Thalmann to settle $2.5M fee dispute; mutual release and arbitration dismissal.","Regained compliance with NYSE American Section 1003(a) as stockholders' equity exceeds $6M as of Oct 18, 2025.","Compliance restored after $16.5M Series H Preferred Stock offering in July 2025; .BC indicator to be removed.","Company now focusing on advancing ONP-002 concussion treatment into Phase IIa trials in Australia and planning U.S. Phase IIb."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018725","json":"https://secwatch.observer/filing/0001493152-25-018725.json","markdown":"https://secwatch.observer/filing/0001493152-25-018725.md","text":"https://secwatch.observer/filing/0001493152-25-018725.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315225018725/0001493152-25-018725-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315225018725/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:57:58.790638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}